NCT05220761

Brief Summary

In this study the investigators will assess the validity, reliability and acceptability of utilizing family members to complete a delirium screen using the Cornell Assessment of Pediatric Delirium (CAPD).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
235

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2021

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 3, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

August 9, 2021

Completed
6 months until next milestone

First Posted

Study publicly available on registry

February 2, 2022

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
Last Updated

November 3, 2022

Status Verified

October 1, 2022

Enrollment Period

2.8 years

First QC Date

June 3, 2021

Last Update Submit

October 31, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Validity of delirium screening by caregivers

    Evaluate the validity of delirium screening by family or caregivers using the cornel assessment of pediatric delirium on their own children while they are admitted to a PICU

    1-28 days

Secondary Outcomes (3)

  • Healthcare professional acceptability of family administered delirium assessment

    Up to 1 year

  • Family/caregiver acceptability of family administered delirium assessment

    Up to 1 year

  • Correlation between absolute score of Richmond Agitation and sedation Scale and State Behavioral Scale.

    1-28 days

Interventions

Cornell Assessment of Pediatric Delirium is a diagnostic test for PICU delirium State Behavioral Scale and Richmond Agitation and Sedation Scale are diagnostic tests for sedation and agitation in children

Also known as: State Behavioral Scale, Richmond Agitation and Sedation Scale

Eligibility Criteria

AgeUp to 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

Children admitted to 2 PICUs in Canada with an expected length of stay of \>/= 48 hours

You may qualify if:

  • Admitted to Alberta Children's Hospital or McMaster Children's Hospital PICU during study enrollment period
  • Anticipated length of stay in PICU \>/=48 hours
  • Substitute decision maker with the ability to provide informed consent
  • Primary caregiver available for CAPD assessments,
  • Primary caregiver is defined as the person primarily responsible for the care and upbringing of a child and could include: Parents, designated older sibling, foster parents/guardians, or grandparents, who fulfill this definition. There may be more than one primary caregiver for each child
  • Translated CAPD and educational materials available in primary spoken language (French, Chinese, Italian or Spanish)

You may not qualify if:

  • I. Anticipated discharge/transfer within 24 hours II. Family member unable to understand the instructions for CAPD assessment
  • a. This will be identified by the research assistant in collaboration with the bedside care team. i.e. language/cognitive barrier III. Child in irreversible coma (i.e. persistent vegetative state, RASS -4/SBS -2 or less and not reversible)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Laurie A. Lee

Calgary, Alberta, T2T 5T3, Canada

Location

McMaster Children's Hospital

Hamilton, Ontario, Canada

Location

MeSH Terms

Conditions

Delirium

Condition Hierarchy (Ancestors)

ConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental Disorders

Study Officials

  • Laurie A. Lee, MN

    University of Calgary

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Adjunct Clinical Associate

Study Record Dates

First Submitted

June 3, 2021

First Posted

February 2, 2022

Study Start

August 9, 2021

Primary Completion

June 1, 2024

Study Completion

June 1, 2024

Last Updated

November 3, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share

Locations